BIOMAT Database Logo BIOMAT Database Logo

Developmental changes in lung cGMP phosphodiesterase-5 activity, protein, and message. 1998

K A Hanson, and F Burns, and S D Rybalkin, and J W Miller, and J Beavo, and W R Clarke
Department of Pediatrics, Department of Anesthesiology, and Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington, USA.

During transitional circulation, the pulmonary vascular bed undergoes a rapid and profound reduction in both tone and vascular smooth-muscle (VSM) content. 3',5'-Guanylate cyclic monophosphate (cGMP) is a crucial mediator in the regulation of pulmonary vascular resistance (PVR) and VSM proliferation. Hydrolysis of cGMP is achieved predominately by cGMP-specific phosphodiesterases (PDEs). Among the cGMP-specific PDEs, PDE5 is quantitatively prevalent in lung tissue. We have investigated the levels of pulmonary PDE5 enzymatic activity, protein, and messenger RNA (mRNA) in ovine and mouse lung during perinatal development. We report that within 1 h following birth, PDE5 activity, protein, and mRNA levels decrease in both species, in a manner that correlates with known decreases in PVR in early transition. However, from 4 to 7 d following birth, a secondary increase in PDE5 activity, protein, and mRNA occurs in both ovine and mouse lung, suggesting a complex regulation of PVR and VSM proliferation in late perinatal development. Our data imply that PDE5 may be an important mediator in the regulation of PVR in normal and possibly in pathologic states, and may ultimately provide a basis for PDE5 inhibitors as a treatment for pulmonary hypertension.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D010727 Phosphoric Diester Hydrolases A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4. Phosphodiesterase,Phosphodiesterases,Hydrolases, Phosphoric Diester
D011652 Pulmonary Circulation The circulation of the BLOOD through the LUNGS. Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D006152 Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) Guanosine Cyclic 3',5'-Monophosphate,Guanosine Cyclic 3,5 Monophosphate,Guanosine Cyclic Monophosphate,Guanosine Cyclic-3',5'-Monophosphate,3',5'-Monophosphate, Guanosine Cyclic,Cyclic 3',5'-Monophosphate, Guanosine,Cyclic Monophosphate, Guanosine,Cyclic-3',5'-Monophosphate, Guanosine,GMP, Cyclic,Guanosine Cyclic 3',5' Monophosphate,Monophosphate, Guanosine Cyclic
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals

Related Publications

K A Hanson, and F Burns, and S D Rybalkin, and J W Miller, and J Beavo, and W R Clarke
cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5.
June 2003, The Biochemical journal,
K A Hanson, and F Burns, and S D Rybalkin, and J W Miller, and J Beavo, and W R Clarke
Partial reconstitution of photoreceptor cGMP phosphodiesterase characteristics in cGMP phosphodiesterase-5.
June 2001, The Journal of biological chemistry,
K A Hanson, and F Burns, and S D Rybalkin, and J W Miller, and J Beavo, and W R Clarke
Effectors of rat lung cGMP binding protein-phosphodiesterase.
January 1985, Current topics in cellular regulation,
K A Hanson, and F Burns, and S D Rybalkin, and J W Miller, and J Beavo, and W R Clarke
Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity.
November 1998, The American journal of physiology,
K A Hanson, and F Burns, and S D Rybalkin, and J W Miller, and J Beavo, and W R Clarke
Purification of cGMP-binding protein phosphodiesterase from rat lung.
January 1988, Methods in enzymology,
K A Hanson, and F Burns, and S D Rybalkin, and J W Miller, and J Beavo, and W R Clarke
Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase.
September 1990, The Journal of biological chemistry,
K A Hanson, and F Burns, and S D Rybalkin, and J W Miller, and J Beavo, and W R Clarke
Conformation changes, N-terminal involvement, and cGMP signal relay in the phosphodiesterase-5 GAF domain.
December 2010, The Journal of biological chemistry,
K A Hanson, and F Burns, and S D Rybalkin, and J W Miller, and J Beavo, and W R Clarke
Assays of G protein/cGMP-phosphodiesterase interactions.
January 2002, Methods in enzymology,
K A Hanson, and F Burns, and S D Rybalkin, and J W Miller, and J Beavo, and W R Clarke
Developmental regulation and properties of the cGMP-specific phosphodiesterase in Dictyostelium discoideum.
May 1984, Developmental biology,
K A Hanson, and F Burns, and S D Rybalkin, and J W Miller, and J Beavo, and W R Clarke
[Methylation of 3',5'-cGMP phosphodiesterase in retinal photoreceptor membranes].
January 1987, Biokhimiia (Moscow, Russia),
Copied contents to your clipboard!